Ruud H. Brakenhoff

ORCID: 0000-0003-3251-5378
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Cancer Studies
  • Oral Health Pathology and Treatment
  • Cancer Genomics and Diagnostics
  • Cancer-related Molecular Pathways
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Molecular Biology Techniques and Applications
  • DNA Repair Mechanisms
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • MicroRNA in disease regulation
  • FOXO transcription factor regulation
  • Salivary Gland Tumors Diagnosis and Treatment
  • Cancer-related gene regulation
  • Gene expression and cancer classification
  • HER2/EGFR in Cancer Research
  • Genomic variations and chromosomal abnormalities
  • Peptidase Inhibition and Analysis
  • Genomics and Chromatin Dynamics
  • Radiomics and Machine Learning in Medical Imaging
  • Cervical Cancer and HPV Research
  • Oral and Maxillofacial Pathology
  • Esophageal Cancer Research and Treatment
  • Monoclonal and Polyclonal Antibodies Research

Vrije Universiteit Amsterdam
2010-2025

Amsterdam University Medical Centers
2018-2025

Cancer Center Amsterdam
2011-2025

Amsterdam UMC Location Vrije Universiteit Amsterdam
2015-2025

Erasmus MC
2024

MRC Holland (Netherlands)
2024

The Netherlands Cancer Institute
1998-2023

Dutch Cancer Society
2023

University of Amsterdam
1994-2021

Fondazione IRCCS Istituto Nazionale dei Tumori
2020

Abstract Human papillomavirus type 16 (HPV16) plays a role in the development of subgroup head and neck squamous cell carcinomas (HNSCC). However, uncertainty exists about true impact HPV this tumor as conflicting reports have been published with prevalence rates from 0 to 100%. We aimed find detection algorithm biologically thus clinically meaningful infection, applicable for high‐throughput screening frozen formalin‐fixed paraffin embedded (FFPE) specimens. By considering E6 oncogene...

10.1002/ijc.22980 article EN International Journal of Cancer 2007-08-06

Background: Transcriptionally active high-risk human papilloma viruses (HPVs), particularly HPV type 16 (HPV16), are found in a subset of head and neck squamous-cell carcinomas (HNSCCs). HPV16-associated carcinogenesis is mediated by expression the viral E6 E7 oncoproteins, which cause deregulation cell cycle inactivating p53 pRb, respectively. We tested hypothesis that HPV-associated HNSCCs display pattern genetic alterations different from those without DNA. Methods: Polymerase chain...

10.1093/jnci/djh183 article EN JNCI Journal of the National Cancer Institute 2004-07-06
Sjors G. J. G. In ‘t Veld Mohammad Arkani Edward P. Post Mafalda Antunes‐Ferreira Silvia D’Ambrosi and 95 more Daan C.L. Vessies Lisa Vermunt Adrienne Vancura Mirte Muller Anna-Larissa N. Niemeijer Jihane Tannous Laura L. Meijer Tessa Y. S. Le Large Giulia Mantini Niels E. Wondergem Kimberley M. Heinhuis Sandra van Wilpe J. Smits Esther E.E. Drees Eva Roos Cyra E Leurs Lee-Ann Tjon Kon Fat Ewoud J. van der Lelij Govert Dwarshuis Maarten J. Kamphuis Lisanne E. Visser Romée Harting Annemijn Gregory Markus Schweiger Laurine E. Wedekind Jip Ramaker Kenn Zwaan Heleen Verschueren Idris Bahce Adrianus J. de Langen Egbert F. Smit Michel M. van den Heuvel Koen J. Hartemink Marijke J. E. Kuijpers Mirjam G.A. oude Egbrink Arjan W. Griffioen Rafael Rossel T. Jeroen N. Hiltermann Elizabeth Lee-Lewandrowski Kent Lewandrowski Philip C. De Witt Hamer Mathilde C.M. Kouwenhoven Jaap C. Reijneveld William P. J. Leenders Ann Hoeben Irma M. Verdonck‐de Leeuw C. René Leemans Robert J. Baatenburg de Jong Chris H.J. Terhaard Robert P. Takes Johannes A. Langendijk Saskia C.A. de Jager Adriaan O. Kraaijeveld Gerard Pasterkamp Minke Smits Jack A. Schalken Sylwia Łapińska‐Szumczyk Anna Łojkowska Anna J. Żaczek Henk M. Lokhorst Niels W.C.J. van de Donk Inger S. Nijhof Henk-Jan Prins Josée M. Zijlstra Sander Idema Johannes C. Baayen Charlotte E. Teunissen Joep Killestein Marc G. Besselink Lindsay Brammen Thomas Bachleitner‐Hofmann Farrah J. Mateen John Th. M. Plukker Michal Heger Quirijn de Mast Ton Lisman D. Michiel Pegtel Harm Jan Bogaard Jacek Jassem Anna Supernat Niven Mehra Winald R. Gerritsen Cor D. de Kroon Christianne Lok Jurgen M.J. Piek Neeltje Steeghs Winan J. van Houdt Ruud H. Brakenhoff Gabe S. Sonke Henk M.W. Verheul Elisa Giovannetti Geert Kazemier Siamack Sabrkhany Ed Schuuring Erik A. Sistermans

Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets involved in cancer progression and considered a promising biosource detection, as they alter their RNA content upon local systemic cues. We show that tumor-educated platelet (TEP) RNA-based blood tests enable the of 18 types. With 99% specificity asymptomatic controls, thromboSeq correctly detected presence two-thirds 1,096 samples stage I–IV half 352 I–III...

10.1016/j.ccell.2022.08.006 article EN cc-by Cancer Cell 2022-09-01

High-risk human papillomaviruses (HPVs) have been proposed to be associated with a subset of head and neck cancers (HNSCCs). However, clear biological evidence linking HPV-mediated oncogenesis the development HNSCC is hardly available. An important mechanism underlying carcinogenesis inactivation p53 by HPV E6 oncoprotein. In present study we investigated this relationship between HNSCC. total 84 tumors were analyzed for presence high-risk nucleic acids DNA polymerase chain reaction-enzyme...

10.1002/ijc.1313 article EN International Journal of Cancer 2001-01-01

Abstract Human papillomavirus (HPV) infection has been etiologically linked to oropharyngeal squamous cell carcinoma (OPSCC). The prevalence of HPV‐positive OPSCC varies between studies, ranging from 20 90%. This may be related the lack a standardized HPV detection assay as well time period in which is investigated, rising incidence rates are reported over last decades. Here, we validated our previously defined test algorithm for formalin‐fixed paraffin‐embedded (FFPE) tumor specimen...

10.1002/ijc.27821 article EN International Journal of Cancer 2012-09-05

Based on recent genetic studies, we propose a progression model for the development of oral squamous cell carcinoma. In initial phase, stem acquires alteration; subsequently patch is formed, clonal unit consisting with its daughter cells that all share DNA alteration. The next critical step conversion into an expanding field as result additional alterations. This mucosal replaces normal epithelium and in cavity such fields have been detected dimensions over 7 cm diameter. Sometimes these are...

10.1111/j.1600-0714.2004.00225.x article EN Journal of Oral Pathology and Medicine 2004-06-16

Human papillomavirus (HPV) positive oropharyngeal cancer (oropharyngeal squamous cell carcinoma, OPSCC) is biologically and clinically different from HPV negative OPSCC. Here, we evaluate the use of a radiomic approach to identify status OPSCC.Four independent cohorts, totaling 778 OPSCC patients with determined by p16 were collected. We randomly assigned 80% all data for model training (N = 628) 20% validation 150). On pre-treatment CT images, 902 features calculated gross tumor volume....

10.1259/bjr.20170498 article EN cc-by British Journal of Radiology 2018-02-16

Recent studies have reported that p16 protein overexpression qualifies as a surrogate marker identifying an oncogenic human papillomavirus (HPV) infection in oropharyngeal squamous cell carcinoma (OPSCC). However, there is still percentage of OPSCCs are positive for immunohistochemistry (p16 IHC) but lack HPV DNA. The objective this study was to characterize group at the molecular level by performing sensitive DNA- and RNA-based PCR methods genetic profiling. All patients diagnosed with...

10.1002/ijc.28580 article EN International Journal of Cancer 2013-10-31
Coming Soon ...